Biodimension Technology Private Limited is a biotechnology company headquartered in Bangalore, Karnataka, India. The firm specializes in developing and manufacturing biofabricated human tissue models for research and testing applications.
Subscribe to see Biodimension’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Biodimension is a medical supplies company headquartered in India. Its most recent funding round raised $961,120 in June 2026. Xcout tracks 3 named people at Biodimension, including Manojkumar S. (Co-founder and CEO).
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| — | $961,120 | 5 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A few of Biodimension's closest competitors — see the full list of competitors and alternatives →
iOrganBio is a biotechnology company founded in 2024 that develops AI-powered platforms for the precision engineering and manufacturing of human cells and organoids. The company's CellForge platform aims to create reproducible human cell models for research applications, including cardiac disease studies and biological simulation.
Fluicell develops precision-engineered biological tissues and single-cell bioprinting technologies for regenerative medicine and drug screening. Using its proprietary platforms, including Nexocyte and Biopixlar, the company creates transplantable tissues to target diseases such as type 1 diabetes and provides advanced tools and screening models for pharmaceutical and academic partners.
Bit Bio is a UK biotechnology company that develops technologies for precisely programming human cells, including its opti-ox platform for producing consistent, scalable cell types. It serves biomedical researchers, drug developers, and regenerative-medicine and cell-therapy developers with engineered human cells and related tools.
Obatala Sciences, Inc. is a biotechnology company that provides organ-on-a-chip solutions for research, with its office located in New Orleans, Louisiana.
Established in 2010 and headquartered in Tokyo, Japan, Cyfuse Biomedical K.K. focuses on the creation, production, and distribution of regenerative medicine solutions. The company is actively involved in developing cell-based products for therapeutic regeneration, and it also undertakes contract work for cellular product research and development. Furthermore, Cyfuse Biomedical offers advanced Bio 3D Printers, which are instrumental in regenerating a variety of tissues and organs, including cartilage, bones, blood vessels, and nerves. Their specialized equipment includes 'regenova,' a bio 3D printer enabling three-dimensional cell stacking, and 'S-PIKE,' designed for forming complex 3D structures from cells.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.